Retinoic acid-induced RB (retinoblastoma) hypophosphorylation enhanced by CGP 52411 (4,5-dianilinophthalimide), an EGF family tyrosine kinase receptor inhibitor

European Journal of Cell Biology

Volumn 69, Issue 4, 1996, Pages 327-334

  Yen, Andrew ^a   Soong, Stephen ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

EGF; RB protein; Retinoblastoma tumor suppressor; Retinoic acid; Vitamin D3

Indexed keywords

CALCITRIOL; CGP 53411; ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR; PHTHALIMIDE DERIVATIVE; PROTEIN TYROSINE KINASE; RETINOBLASTOMA PROTEIN; RETINOIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; DEPHOSPHORYLATION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE;

EID: 0029923810     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Anzai, N., H. Kawabata, T. Hirama, H. Masutani, M. Ohmori, Y. Yoshida, M. Okuma: Marked apoptosis of human myelomonocytic leukemia cell line p39: Significance of cellular differentiation. Leukemia 8, 446-453 (1994).
2. Aoudjit, F., M. Bosse, C. Stratowa, G. Voraberger, M. Audette: Regulation of intercellular adhesion molecule-1 expression by retinoic acid: Analysis of the 5′-regulatory region of the gene. Int. J. Cancer 58, 543-549 (1994).
3. Breitman, T. R., S. E. Selonick, S. J. Collins: Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA 77, 2936-2940 (1980).
4. Buchdunger, E., U. Trinks, H. Mett, U. Regenass, M. Mueller, T. Meyer, E. McGlynn, L. A. Pinna, P. Traxler, N. B. Lydon: 4,5-Dianilinophthalmide: A protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity. Proc. Natl. Acad. Sci. USA 91, 2334-2338 (1994).
5. Care, A., U. Testa, A. Bassani, E. Tritarelli, E. Montesoro, P. Samoggia, L. Cianetti, C. Peschle: Coordinate expression and proliferative role of HOXB gene in activated adult T lymphocytes. Mol. Cell. Biol. 14, 4872-4877 (1994).
6. Chen, P. L., P. Scully, J. Y. Shew, J. Y. Wang, W. H. Lee: Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58, 1193-1198 (1989).
7. Collins, S. J., R. C. Gallo, R. E. Gallagher: Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 270, 347-349 (1977).
8. Elliott, S., K. Taylor, S. White, R. O. Rodwell, P. Marlton, D. Meagher, J. Wiley, D. Taylor, S. Wright, P. Timms: Proof of differentiative mode of action of all-trans retinoic acid in acute promyelocytic leukemia using X-linked clonal analysis. Blood 79, 1916-1919 (1992).
9. Fenaux, P., S. Castaigne, H. Dombret, E. Archimbaud, M. Duarte, P. Morel, T. Lamy, H. Tilly, A. Guerci, F. Maloisel, D. Bordessoule, A. Sadoun, P. Tiberghien, N. Fegueux, M. T. Daniel, C. Chomienne, L. Degos: All-trans retinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: A pilot study on 26 cases. Blood 80, 2176-2181 (1992).
10. Hanada, M., S. Krajewski, S. Tanaka, D. Cazals-Hatem, B. A. Spengler, R. A. Ross, J. L. Biedler, J. C. Reed: Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells. Cancer Res. 53, 4978-4986 (1993).
11. Ludlow, J. W., J. A. DeCaprio, C.-M. Huang, W.-H Lee, E. Paucha, D. M Livingston, SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell 56, 57-65 (1989).
12. Katagiri, K., T. Katagiri, Y. Koyama, M. Morikawa, T. Yamamoto, T. Yoshida: Expression of scr family genes during monocytic differentiation of HL-60 cells. J. Immunol. 146, 701-707 (1991).
13. Kwon, H. J., M. Yoshida, Y. Fukui, S. Horinouchi, T. Beppu: Potent and specific inhibition of p60v-src protein kinase both in vivo and in vitro by Radicicol. Cancer Res. 52, 6926-6930 (1992).
14. Labbaye, C., M. Valtieri, U. Testa, A. Giampaolo, E. Meccia, P. Sterpetti, T. Parolini, E. Pelosi, D. Bulgarini, Y. E. Cayre, C. Peschle: Retinoic acid downmodulates erythroid differentiation and GATA1 expression in purified adult-progenitor culture. Blood 83, 651-656 (1994).
15. Langston, A. W., L. J. Gudas: Retinoic acid and homeobox gene regulation. Curr. Opin. Gen. Dev. 4, 550-555 (1994).
16. Larsen, F. G., J. J. Voorhees, A. Astrom: Retinoic acid induces expression of early growth response gene-1 (Egr-1) in human skin in vivo and in cultured skin fibroblasts. J. Invest. Dermatol. 102, 730-733 (1994).
17. Lotan, R.: Suppression of squamous cell carcinoma growth and differentiation by retinoids. Cancer Res. 54, 1987S-1990S (1994).
18. Ludlow, J. W., J. A. DeCaprio, C.-M. Huang, W.-H. Lee, E. Paucha, D. M. Livingston: SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell 56, 57-65 (1989).
19. Lydon, N. B., E. Buchdunger, H. Mett, U. Regenass, M. Muller, U. Trinks, P. Traxler: Biological profile of CGP 52411: A tyrosine protein kinase inhibitor with selectivity for the EGF-receptor enzyme family. J. Cell Biochem. 17, 235 (1993).
20. Manohar, C. F., M. R. Furtado, H. R. Salwen, S. L. Cohn: Hox gene expression in differentiating human neuroblastoma cells. Biochem. Mol. Biol. Int. 30, 733-741 (1993).
21. Marshall, H., M. Studer, H. Popperl, S. Aparicio, A. Kuroiwa, S. Brenner, R. Krumlauf: A conserved retinoic acid response element required for early expression of the homeobox gene Hoxb-1. Nature 370, 567-571 (1994).
22. Mihara, K., X.-R. Cao, A. Yen, S. Chandler, B. Driscoll, A. L. Murphree, A. T'Ang, Y. K. T. Fung: Cell-cycle dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 246, 1300-1303 (1989).
23. Saunders, N. A., A. M. Jetten: Control of growth regulatory and differentiation-specific genes in human epidermal keratinocytes by interferon gamma: Antagonism by retinoic acid and transforming growth factor beta-1. J. Biol. Chem. 269, 2016-2022 (1994).
24. Sun, G. L., Y. G. Huang, X. F. Chang, G. S. Juang, T. Zhang: Clinical study on all-trans retinoic acid in treatment of 544 cases of acute promyelocytic leukemia treated. Chin. J. Hematol. 13, 135 (1992).
25. Van Bockstaele, D. R., M. Lenjou, H. W. Snoeck, F. Lardon, P. Stryckmans, M. E. Peetermans: Direct effects of 13-CIS and all-trans retinoic acid on normal bone marrow BM progenitors comparative study on BM mononuclear cells and on isolated CD34 positive BM cells. Ann. Hematol. 66, 61-66 (1993).
26. Warrell, R. P., Jr., S. R. Frankel, W. H. Miller, Jr., D. A. Scheinberg, L. M. Itri, W. N. Hittelman, R. Vyas, M. Andreeff, A. Tafuri, A. Jakubowski, J. Gabrilove, M. Gordon, E. Dmitrovsky: Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N. Engl. J. Med. 324, 1385-1393 (1991).
27. Willman, C. L., C. C. Stewart, T. L. Longacre, D. R. Head, R. Habbersett, S. F. Ziegler, R. M. Perlmutter: Expression of the c-fgr and hck protein-tyrosine kinases in acute myeloid leukemic blasts is associated with early commitment and differentiation events in the monocytic and granulocytic lineages. Blood 77, 726-734 (1991).
28. Wood, H., G. Pall, K. G. Morriss: Exposure to retinoic acid before or after the onset of somitogenesis reveals separate effects on rhombomeric segmentation and 3′ HoxB gene expression domains. Development 120, 2279-2285 (1994).
29. Yen, A., M. E. Forbes: C-myc down regulation and precommitment in HL-60 cells due to bromodeoxyuridine. Cancer Res. 50, 1411-1420 (1990).
30. Yen, A., S. Varvayanis: Late dephosphorylation of the RB protein in G2 during the process of induced cell differentiation. Exp. Cell Res. 214, 250-257 (1994).
31. Yen, A., S. Varvayanis: RB tumor suppressor gene expression responds to DNA synthesis inhibitors. In Vitro Cell. Dev. Biol. 28, 669-672 (1992).
32. Yen, A., S. Chandler, M. E. Forbes, Y.-K. Fung, A. T'Ang, R. Pearson: Coupled down-regulation of the RB retinoblastoma and c-myc genes antecedes cell differentiation: possible role of RB as a "status quo" gene. Eur. J. Cell Biol. 57, 210-221 (1992).
33. Yen, A., M. E. Forbes, S. Varvayanis, M. L. Tykocinski, R. K. Groger, J. D. Platko: C-FMS dependent HL-60 cell differentiation and regulation of RB gene expression. J. Cell. Physiol. 157, 379-391 (1993).
34. Yen, A., S. L. Reece, K. L. Albright: Dependence of HL-60 myeloid cell differentiation on continuous and split retinoic acid exposures: precommitment memory associated with altered nuclear structure. J. Cell. Physiol. 118, 277-286 (1984).
35. Yen, A., S. Soong, H. J. Dwon, M. Yoshida, T. Beppu, S Varvayanis: Enhanced cell differentiation when RB is hypophosphorylated and down regulated by Radicicol, a SRC-kinase inhibitor. Exp. Cell Res. 214, 163-171 (1994).
36. Yen, A., M. Williams, J. D. Platko, C. Der, M. Hisaka: Expression of activated RAF accelerates cell differentiation and RB protein down-regulation but not hypophosphorylation. Eur. J. Cell Biol. 65, 103-113 (1994).
37. Zacksenhaus, E., R. Bremner, Z. Jiang, R. M. Gill, M. Muncaster, M. Sopta, R. A. Phillips, B. L. Gallie: Unraveling the function of the retinoblastoma gene. Adv. Cancer Res. 61, 115-141 (1989).